X4 Pharmaceuticals (XFOR) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

XFOR is expected to report earnings to fall 137.47% to -16 cents per share on November 07

X4 Pharmaceuticals XFOR Stock Earnings Reports

Q3'24

Est.

$-0.17

Q2'24

Beat

by $0.46

Q1'24

Missed

by $0.12

Q4'23

Beat

by $0.05

Q3'23

Beat

by $0.14

The last earnings report on August 08 showed earnings per share of 44 cents, beating the estimate of 0 cents. With 633.52K shares outstanding, the current market capitalization sits at 113.79M.

View a ticker or compare two or three

Compare

XFOR

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For XFOR
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a biotechnology company which engages in developing human antibodies for treating infectious diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

61 North Beacon Street

Phone

+1 857 529-8300

Employees

Web

https://www.x4pharma.com